Alimera makes 4th bid for eye treatment approval from FDA
Alimera Sciences Inc. said it has applied a fourth time for U.S. regulatory approval to start selling an eye implant that delivers a drug to treat a form of blindness in diabetes patients. Alimera said it had provided a safety update and responded to questions the U.S. Food and Drug Administration raised in October, when it rejected marketing approval for the treatment for a third time.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063